Immune Reconstitution and Infection Patterns after Early Alemtuzumab and Reduced Intensity Transplantation for Nonmalignant Disorders in Pediatric Patients
Sima Bhatt(Washington University in St. Louis), Shalini Shenoy(Washington University in St. Louis), Jennifer Willert(Unknown), Lisa Murray(Washington University in St. Louis), Naynesh Kamani(American Association of Blood Banks), Michael Grimley(Cincinnati Children's Hospital Medical Center), Ginny Schulz(St. Louis Children's Hospital), Monica Hente(St. Louis Children's Hospital), Kathryn Trinkaus(Washington University in St. Louis), Paul R. Haut(Indiana University Health), Lolie C. Yu(Louisiana State University), Martin Andreánsky(University of Miami Health System), David A. Jacobsohn(Children's National), Jeffrey J. Bednarski(Washington University in St. Louis), Sonali Chaudhury(Northwestern University), Jignesh Dalal(Rainbow Babies & Children's Hospital), Jennifer Jaroscak(Medical University of South Carolina), Julia Berg(St. Louis Children's Hospital), Jeffrey Davis(BC Children's Hospital), Ka Wah Chan(Methodist Children’s Hospital), Michael L. Nieder(Rainbow Babies & Children's Hospital), Roberta H. Adams(Mayo Clinic in Arizona), Michael A. Pulsipher(Primary Children's Hospital), Gregory A. Hale(Johns Hopkins University), Robert J. Hayashi(Washington University in St. Louis)
Cited by 16
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|442